What are the side effects of Norvasc (amlodipine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of Norvasc (Amlodipine)

Peripheral edema is the most common side effect of amlodipine, occurring in up to 10.8% of patients taking the 10mg dose. 1

Common Side Effects

  • Peripheral edema: Occurs in a dose-dependent manner (1.8% at 2.5mg, 3.0% at 5mg, and 10.8% at 10mg) 1

    • More common in women (14.6%) than men (5.6%) 1
    • Caused by precapillary/postcapillary pressure imbalance due to arterial dilation with minimal effect on venous tone 2
    • Typically affects lower limbs, particularly feet and ankles 2
    • Not associated with fluid retention or volume overload 2
  • Dizziness: Occurs in 1.1-3.4% of patients (dose-dependent) 1

  • Flushing: Occurs in 0.7-2.6% of patients (dose-dependent) 1

    • More common in women (4.5%) than men (1.5%) 1
  • Palpitations: Occurs in 0.7-4.5% of patients (dose-dependent) 1

    • More common in women (3.3%) than men (1.4%) 1
  • Fatigue: Reported in 4.5% of patients 1

  • Nausea: Reported in 2.9% of patients 1

  • Abdominal pain: Reported in 1.6% of patients 1

  • Somnolence (drowsiness): Reported in 1.4% of patients 1

    • More common in women (1.6%) than men (1.3%) 1
  • Headache: Common side effect, though interestingly a meta-analysis found reduced headache incidence with amlodipine compared to placebo (7.9% vs 10.9%), particularly at lower doses 3

Less Common Side Effects (<1%)

  • Cardiovascular: Arrhythmia (including ventricular tachycardia and atrial fibrillation), bradycardia, chest pain, peripheral ischemia, syncope, tachycardia, vasculitis 1

  • Neurological: Hypoesthesia, peripheral neuropathy, paresthesia, tremor, vertigo 1

  • Gastrointestinal: Anorexia, constipation, dysphagia, diarrhea, flatulence, pancreatitis, vomiting, gingival hyperplasia 1

  • Musculoskeletal: Arthralgia, arthrosis, muscle cramps, myalgia 1

  • Psychiatric: Sexual dysfunction (male and female), insomnia, nervousness, depression, abnormal dreams, anxiety, depersonalization 1

  • Respiratory: Dyspnea, epistaxis 1

  • Dermatological: Angioedema, erythema multiforme, pruritus, rash (erythematous and maculopapular) 1

    • Rare cases of hyperpigmentation of oral mucosa and skin have been reported 4
  • Special senses: Abnormal vision, conjunctivitis, diplopia, eye pain, tinnitus 1

  • Urinary: Micturition frequency, micturition disorder, nocturia 1

  • Other: Dry mouth, increased sweating, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia 1

  • Post-marketing: Gynecomastia (reported infrequently) 1

Special Considerations

  • Elderly patients: Greater antihypertensive effects due to decreased baroreceptor response and age-related increase in drug exposure 5

    • Should initiate at lower doses and titrate cautiously 5
  • Heart failure: Amlodipine is reasonably well tolerated in patients with mild LV dysfunction 5

    • Should be avoided in patients with pulmonary edema or severe LV dysfunction 5
  • Concomitant medications:

    • Can be used with nitroglycerin 1
    • Has minimal effect on myocardial contractility or cardiac conduction compared to other calcium channel blockers 6
  • Children: Edema may be less common in pediatric patients compared to adults, but cases of generalized edema have been reported 7

Risk Reduction Strategies

  • Dose optimization: Lower doses (2.5-5mg) result in significantly lower rates of edema compared to higher doses (10mg) 3

    • Consider starting at the lowest effective dose, particularly in elderly patients 5
  • Monitoring: Watch for early signs of peripheral edema, especially in the ankles and feet 2

  • Patient education: Inform patients about potential side effects and when to contact their healthcare provider 1

  • Alternative options: If edema is problematic, consider alternative antihypertensive medications or combination therapy that allows for lower amlodipine dosing 2

References

Guideline

Amlodipine-Induced Peripheral Edema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Amlodipine associated hyperpigmentation.

Saudi medical journal, 2004

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Amlodipine: a new calcium antagonist.

American journal of hospital pharmacy, 1994

Research

Amlodipine: The double edged sword.

Journal of paediatrics and child health, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.